Detailed information for compound 1977825

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 449.466 | Formula: C21H23N9O3
  • H donors: 3 H acceptors: 7 LogP: 0.76 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(c1nc(cnc1Nc1cncnc1)C1CC1)Nc1cnn(c1C(=O)N[C@H]1COCC1)C
  • InChi: 1S/C21H23N9O3/c1-30-18(21(32)27-13-4-5-33-10-13)16(9-25-30)29-20(31)17-19(26-14-6-22-11-23-7-14)24-8-15(28-17)12-2-3-12/h6-9,11-13H,2-5,10H2,1H3,(H,24,26)(H,27,32)(H,29,31)/t13-/m1/s1
  • InChiKey: SUPYFVMUZAUCPL-CYBMUJFWSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens phosphodiesterase 10A Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_135363 All targets in OG5_135363
Echinococcus granulosus cAMP and cAMP inhibited cGMP 3'5' cyclic Get druggable targets OG5_135363 All targets in OG5_135363
Brugia malayi Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative Get druggable targets OG5_135363 All targets in OG5_135363
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_135363 All targets in OG5_135363
Echinococcus multilocularis cAMP and cAMP inhibited cGMP 3',5' cyclic Get druggable targets OG5_135363 All targets in OG5_135363

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma brucei cAMP-specific phosphodiesterase phosphodiesterase 10A 789 aa 666 aa 30.2 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0085 0.1896 0.2756
Trichomonas vaginalis cAMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Leishmania major DNA polymerase kappa, putative 0.0015 0.0121 0.2133
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.0033 0.0566 1
Trichomonas vaginalis cAMP-specific phosphodiesterase, putative 0.0033 0.0566 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Brugia malayi Hypothetical tyrosinase-like protein C02C2.1 in chromosome III 0.0085 0.1896 0.2666
Trypanosoma brucei DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Trypanosoma brucei DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Loa Loa (eye worm) hypothetical protein 0.0085 0.1896 0.2756
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0033 0.0566 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Trypanosoma cruzi DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Trypanosoma cruzi cAMP specific phosphodiesterase, putative 0.0033 0.0566 1
Trichomonas vaginalis cAMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Schistosoma mansoni tyrosinase precursor 0.0402 1 1
Entamoeba histolytica deoxycytidyl transferase, putative 0.001 0 0.5
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Schistosoma mansoni cgmp-dependent 35-cyclic phosphodiesterase 0.0033 0.0566 0.0566
Trypanosoma cruzi DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Loa Loa (eye worm) hypothetical protein 0.0256 0.6282 0.9129
Mycobacterium tuberculosis Two component sensor histidine kinase DosT 0.0023 0.0335 1
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0033 0.0566 1
Trypanosoma cruzi cAMP specific phosphodiesterase, putative 0.0033 0.0566 1
Echinococcus granulosus dual 3'5' cyclic AMP and GMP phosphodiesterase 0.0033 0.0566 0.0796
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0033 0.0566 1
Onchocerca volvulus 0.0085 0.1896 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Trypanosoma brucei DNA polymerase kappa, putative 0.0022 0.0304 0.537
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Toxoplasma gondii hypothetical protein 0.0023 0.0335 0.5
Loa Loa (eye worm) ShTK domain-containing protein 0.0085 0.1896 0.2756
Trypanosoma brucei DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Trypanosoma brucei DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Brugia malayi ShTK domain containing protein 0.0085 0.1896 0.2666
Mycobacterium tuberculosis Two component sensor histidine kinase DevS 0.0023 0.0335 1
Toxoplasma gondii hypothetical protein 0.0023 0.0335 0.5
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0029 0.0486 0.6568
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0015 0.0121 0.2133
Trypanosoma cruzi DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Trypanosoma cruzi cAMP specific phosphodiesterase, putative 0.0033 0.0566 1
Mycobacterium ulcerans DNA polymerase IV 0.0029 0.0486 1
Brugia malayi polk-prov protein 0.0022 0.0304 0.0427
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0033 0.0566 1
Mycobacterium ulcerans DNA polymerase IV 0.0029 0.0486 1
Loa Loa (eye worm) hypothetical protein 0.0033 0.0566 0.0822
Trichomonas vaginalis cAMP/cGMP cyclic nucleotide phosphodiesterase, putative 0.0033 0.0566 1
Giardia lamblia DINP protein human, muc B family 0.0015 0.0121 0.5
Trypanosoma brucei unspecified product 0.0025 0.0366 0.6464
Trichomonas vaginalis cAMP-specific phosphodiesterase, putative 0.0033 0.0566 1
Loa Loa (eye worm) hypothetical protein 0.028 0.6881 1
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Toxoplasma gondii GAF domain-containing protein 0.0023 0.0335 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0012 0.0039 0.0681
Trypanosoma brucei DNA polymerase IV, putative 0.0029 0.0486 0.8597
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Plasmodium vivax hypothetical protein, conserved 0.0023 0.0335 0.5
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Brugia malayi Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative 0.0289 0.7112 1
Trypanosoma brucei DNA polymerase IV, putative 0.0025 0.0366 0.6464
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Schistosoma mansoni camp/cgmp cyclic nucleotide phosphodiesterase 0.0033 0.0566 0.0566
Echinococcus multilocularis dna polymerase kappa 0.0029 0.0486 0.0684
Trypanosoma brucei cAMP-specific phosphodiesterase 0.0033 0.0566 1
Echinococcus multilocularis cAMP and cAMP inhibited cGMP 3',5' cyclic 0.0289 0.7112 1
Echinococcus granulosus cAMP and cAMP inhibited cGMP 3'5' cyclic 0.0289 0.7112 1
Trypanosoma brucei cAMP-specific phosphodiesterase 0.0033 0.0566 1
Brugia malayi Hypothetical tyrosinase-like protein F21C3.2 in chromosome I 0.0085 0.1896 0.2666
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.0033 0.0566 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0012 0.0039 0.0681
Onchocerca volvulus 0.0085 0.1896 0.5
Brugia malayi Hypothetical tyrosinase-like protein C02C2.1 in chromosome III 0.0085 0.1896 0.2666
Onchocerca volvulus 0.0085 0.1896 0.5
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.0015 0.0121 0.3608
Echinococcus multilocularis dual 3',5' cyclic AMP and GMP phosphodiesterase 0.0033 0.0566 0.0796
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0033 0.0566 1
Plasmodium falciparum GAF domain-related protein, putative 0.0023 0.0335 0.5
Brugia malayi Hypothetical tyrosinase-like protein C02C2.1 in chromosome III 0.0085 0.1896 0.2666
Trypanosoma brucei DNA polymerase kappa, putative 0.0022 0.0304 0.537
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.0033 0.0566 1
Loa Loa (eye worm) hypothetical protein 0.0022 0.0304 0.0442
Onchocerca volvulus 0.0085 0.1896 0.5
Trichomonas vaginalis cone cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0033 0.0566 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Brugia malayi 3'5'-cyclic nucleotide phosphodiesterase family protein 0.0033 0.0566 0.0796
Trypanosoma brucei DNA polymerase kappa, putative 0.0012 0.0039 0.0681
Trypanosoma cruzi DNA polymerase kappa, putative 0.0029 0.0486 0.8597
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.0566 1
Trichomonas vaginalis DNA polymerase eta, putative 0.0029 0.0486 0.6568
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Trichomonas vaginalis cone cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1
Loa Loa (eye worm) tyrosinase 1 0.0085 0.1896 0.2756
Toxoplasma gondii hypothetical protein 0.0023 0.0335 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.0029 0.0486 0.8597
Mycobacterium leprae conserved hypothetical protein 0.0023 0.0335 0.5
Echinococcus granulosus dna polymerase kappa 0.0029 0.0486 0.0684
Loa Loa (eye worm) ShTK domain-containing protein 0.0085 0.1896 0.2756
Trypanosoma brucei DNA polymerase kappa, putative 0.0015 0.0121 0.2133
Brugia malayi Common central domain of tyrosinase family protein 0.0085 0.1896 0.2666
Trichomonas vaginalis cGMP-inhibited 3,5-cyclic phosphodiesterase, putative 0.0033 0.0566 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 3.5 nM BindingDB_Patents: Scintillation Proximity Assay. PDE10 activity of the compounds of the present invention was determined using a Scintillation Proximity Assay (SPA)-based method similar to the one previously described (Fawcett, L. et al., Proc Natl Acad Sci USA (2000) 97(7):3702-3707). The human PDE10A full length assay was performed in 96-well micro titer plates. The reaction mixture of 50 µl contained 20 mM HEPES pH=7.5/10 mM MgCl2/0.05 mg/ml BSA (Sigma cat. # A-7906), 50 nM cGMP (Sigma, cat. # G6129) and 50 nM [3H]-cGMP (GE Healthcare, cat. # TRK392 S.A. 13.2 Ci/mmol), 3.75 ng/well PDE10A enzyme (Enzo Life Science, Lausen, Switzerland cat #SE-534) with or without a specific test compound. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.